These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 17491545)

  • 1. Osteochemonecrosis of jaws and bisphosphonates.
    Khosa AD; Nayyar MS; Beirne JC
    Ir Med J; 2007 Mar; 100(3):410-1. PubMed ID: 17491545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bisphosphonate-associated osteonecrosis: a clinician's reference to patient management.
    Grewal VS; Fayans EP
    Todays FDA; 2008 Aug; 20(8):38-41, 43-6. PubMed ID: 18767452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteonecrosis associated with short-term oral administration of bisphosphonate.
    Takagi Y; Sumi Y; Harada A
    J Prosthet Dent; 2009 May; 101(5):289-92. PubMed ID: 19410063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bisphosphonates and osteonecrosis of the jaws: science and rationale.
    Gutta R; Louis PJ
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Aug; 104(2):186-93. PubMed ID: 17448709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Bisphosphonate-associated osteonecrosis of the jaws 1].
    Allard RH; Lips P; Eekhoff EM; van Merkesteyn JP; van der Waal I
    Ned Tijdschr Tandheelkd; 2007 Oct; 114(10):423-7. PubMed ID: 17972610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A review of the literature on osteonecrosis of the jaw in patients with osteoporosis treated with oral bisphosphonates: prevalence, risk factors, and clinical characteristics.
    Pazianas M; Miller P; Blumentals WA; Bernal M; Kothawala P
    Clin Ther; 2007 Aug; 29(8):1548-58. PubMed ID: 17919538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Avascular mandibular osteonecrosis in association with bisphosphonate therapy: a report on four patients.
    Friedrich RE; Blake FA
    Anticancer Res; 2007; 27(4A):1841-5. PubMed ID: 17649782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Warning: bisphosphonates and osteochemonecrosis of the jaws.
    Flint SR; Sharkey S; Galvin S
    J Ir Dent Assoc; 2006; 52(2):79-83. PubMed ID: 16989369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteonecrosis of the jaws associated with use of risedronate: report of 2 new cases.
    Brooks JK; Gilson AJ; Sindler AJ; Ashman SG; Schwartz KG; Nikitakis NG
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Jun; 103(6):780-6. PubMed ID: 17223592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adverse events and intravenous versus oral bisphosphonate use in patients with osteoporosis and cancer in the U.S.
    Skrepnek GH; Seal B; Tangirala M; Jeffcoat MK; Watts NB; Hay JW
    Gen Dent; 2010; 58(6):484-92; quiz 493-4. PubMed ID: 21062718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bisphosphonates and oral pathology I. General and preventive aspects.
    Ponte Fernández N; Estefania Fresco R; Aguirre Urizar JM
    Med Oral Patol Oral Cir Bucal; 2006 Aug; 11(5):E396-400. PubMed ID: 16878067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteochemonecrosis of the jaws due to bisphosphonate treatments. Update.
    Gómez Font R; Martínez García ML; Olmos Martínez JM
    Med Oral Patol Oral Cir Bucal; 2008 May; 13(5):E318-24. PubMed ID: 18449117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treating osteoporosis: do bisphosphonates really increase the risk of osteonecrosis of the jaw?
    Thompson E; Sheehy C; Barry M; Carey J
    Ir Med J; 2008 Jun; 101(6):166-7. PubMed ID: 18700507
    [No Abstract]   [Full Text] [Related]  

  • 14. Bisphosphonate-induced necrosis of the jaws: a reconstructive nightmare.
    Gevorgyan A; Enepekides DJ
    Curr Opin Otolaryngol Head Neck Surg; 2008 Aug; 16(4):325-30. PubMed ID: 18626250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bisphosphonate-induced osteonecrosis of the jaw.
    Sharma V; Nagaraj S; Choksey U; Hegde A; Samant R; Balakrishnan C
    J Assoc Physicians India; 2011 Aug; 59():516-7. PubMed ID: 21887911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bisphosphonates, osteonecrosis of the jaw, and dental treatment recommendations.
    Radfar L; Masood F
    J Okla Dent Assoc; 2008; 99(7):28-9. PubMed ID: 18595621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Osteonecrosis and bisphosphonates in oral and maxillofacial surgery.
    Chaudhry AN; Ruggiero SL
    Oral Maxillofac Surg Clin North Am; 2007 May; 19(2):199-206, vi. PubMed ID: 18088878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Common musculoskeletal adverse effects of oral treatment with once weekly alendronate and risedronate in patients with osteoporosis and ways for their prevention.
    Bock O; Boerst H; Thomasius FE; Degner C; Stephan-Oelkers M; Valentine SM; Felsenberg D
    J Musculoskelet Neuronal Interact; 2007; 7(2):144-8. PubMed ID: 17627083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between bisphosphonates and jaw osteonecrosis: a study in Wistar rats.
    Maahs MP; Azambuja AA; Campos MM; Salum FG; Cherubini K
    Head Neck; 2011 Feb; 33(2):199-207. PubMed ID: 20848442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Normal serum bone markers in bisphosphonate-induced osteonecrosis of the jaws.
    Lehrer S; Montazem A; Ramanathan L; Pessin-Minsley M; Pfail J; Stock RG; Kogan R
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Sep; 106(3):389-91. PubMed ID: 18554944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.